首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 265 毫秒
1.
《中国兽药杂志》2003,37(11):27-29
根据国外已发表的鸡传染性支气管炎病毒(IBV)S1基因序列设计了一对引物,通过RT-PCR特异性扩增出IBV H120疫苗株的S1基因,产物大小为1.62 kb,与设计相符.同源性比较结果显示,H120株与H52、M41和BEAU株的S1基因核苷酸序列的同源性分别为97.1 %、96.9 %和96.8 %,表明IBV H120疫苗株与标准毒株的S1基因具有高度的同源性.  相似文献   

2.
鸡传染性支气管炎病毒基因型与血清型相关性初步研究   总被引:1,自引:0,他引:1  
为研究鸡传染性支气管炎病毒(IBV)基因型与血清型之间的相关性,本研究以国内不同地区的17株IBV分离株、2株疫苗株(M41、W93)和1株强毒株(X株)为研究对象,经RT-PCR扩增获得20株IBV的S1基因并进行测序.将其分别与GenBank中的20株国内外参考IBV株的S1基因进行序列比较,绘制S1基因系统进化树...  相似文献   

3.
传染性支气管炎病毒(IBV)的Spikel(S1)表面糖蛋白是产生病毒中和抗体的主要诱发基因,使用提纯的S1可以激发抗强毒株攻击的免疫保护。根据这一发现,美国学者Wang等构建了一株包含IBV Mass41株S1复制基因的重组疫苗(rFPV-S1),并对其免疫原性及疫苗效力进行评价。最初,  相似文献   

4.
试验对安徽某蛋鸡场采集的病料进行病毒分离,获得2株鸡传染性支气管炎病毒(IBV),命名为AH01/2020和AH02/2020。对分离的病毒进行鸡胚接种、S1基因测序以及遗传进化分析。结果显示,AH01/2020为LSC/99Ⅰ型,AH02/2020为QX型,2株病毒均可导致鸡胚出现不同程度IBV典型病变,表现为发育不良、蜷缩等。AH01/2020、AH02/2020与参考株S1基因的核苷酸相似性分别为76.7%~97.8%和78.1%~90.9%,与常用疫苗株的S1同源性均偏低,仅76.7%~79.4%,试验结果揭示了我国IBV的基因多样性,为IBV进行遗传监测和研发新型疫苗提供了参考。  相似文献   

5.
根据国外已发表的鸡传染性支气管炎病毒(IBV)S1基因序列设计了一对引物,通过:RT-PCR特异性扩增出IBV H120疫苗株的S1基因,产物大小为1.62kb,与设计相符。同源性比较结果显示,H120株与H52、M41和BEAU株的S1基因核苷酸序列的同源性分别为97.1%、96.9%和96.8%,表明IBV H120疫苗株与标准毒株的S1基因具有高度的同源性。  相似文献   

6.
表达鸡传染性支气管炎病毒S基因的重组新城疫病毒构建   总被引:1,自引:0,他引:1  
为构建以新城疫病毒(NDV)为活毒载体表达鸡传染性支气管炎病毒(IBV)S基因的重组病毒,本研究利用RT-PCR技术,以IBV的Massachusetts41株RNA为模板,通过RT-PCR扩增得到IBV S基因(3534bp),将其插入到NDV感染性克隆pBRN-FL中,构建了含有IBV S基因的重组NDV cDNA克隆pBRN-FL-IBVS。利用磷酸钙转染法,在辅助质粒pBS-NP、pBS-P和pBS-L的共同作用下,将pBRN-FL-IBVS转染表达T7聚合酶重组痘病毒感染的BSR细胞,救获重组NDV(rL-IBVS)。采用RT-PCR检测接种重组病毒的鸡胚尿囊液,结果表明rL-IBVS中含有相应外源基因。IFA试验表明,rL-IBVS可与鸡抗IBV的高免血清发生特异性反应,证明S蛋白在感染的BSR细胞中得到表达。其鸡胚平均致死时间、脑内致病指数和静脉内致病指数等指标显示rL-IBVS保持了亲本疫苗株高滴度的鸡胚生长特性和低致病力特性。本研究采用反向遗传操作技术构建了表达IBV S蛋白的重组NDV,为进一步研制IBV和NDV的重组基因工程活载体疫苗奠定了基础。  相似文献   

7.
根据已发表的鸡传染性支气管炎病毒(IBV)S1基因序列设计了1对引物,通过RT-PCR特异性扩增出DN-1株的S1基因,产物为1.7 kb,与设计相符.同源性比较结果显示,DN-1株与H52、H120株的S1基因核苷酸序列的同源性分别为99.7%、99.2%,表明IBV DN-1分离株与疫苗株的S1基因具有高度的同源性.  相似文献   

8.
本研究通过RT-PCR分别获得了4个国内IBV分离株的S1、M和N基因,并进行了克隆及测序。序列分析结果表明:HaN2-95株的S1、M和N基因核苷酸序列均与IBV H120疫苗株的同源性最高;尽管HaN1-95株的S1基因与IBV H52疫苗株的亲缘关系最近,但是该毒株的M基因和N基因却与IBV Gray株的同源性最高;GX1-98株的S1和M基因均与IBV H52疫苗株的亲缘关系最近,但其N基因却与IBV Gray株和Ark99株有高度的同源性;GX2-98株的S1基因却与IBV Holte株的亲缘关系最近。上述结果提示国内有些IBV分离株的出现可能与疫苗株的使用有关。  相似文献   

9.
鸡传染性支气管炎病毒S1和N基因遗传变异的相关性   总被引:3,自引:0,他引:3  
对国内1992—2005年分离的IBV毒株的纤突蛋白(S1)和核衣壳蛋白(N)基因分别进行克隆测序,结合在GenBank中发表的IBV S1和N基因的序列,对其不同毒株的S1或N基因片段和全长、S1和N基因全长分别进行遗传变异的研究,利用统计学软件SPSS11.5进行同源性相关分析。结果表明:不同IBV毒株N或S1基因片段与其全长之间遗传变异高度相关,核苷酸r≥0.892,氨基酸0.854≤r≤0.968;但S1与N基因全长之间核苷酸的遗传变异相关性相对较低一些,而且有些毒株间S1基因同源性很低(r=0.645),但N基因同源性仍很高,显示每个基因变异的独立性。国内IBV疫苗株之间S1和N基因核苷酸高度同源(S1≥97.3%;N≥90.7%),而野毒株与疫苗株相比S1和N基因同源性均较低(S1≤84.3%;N≤87.1%),这也可能与常规疫苗对IBV野毒株不能有效保护有关。  相似文献   

10.
本研究于2020年从广东省部分地区疑似鸡传染性支气管炎病毒(IBV)感染的病料中分离到7株病毒,对分离的病毒进行S1及N基因序列分析,结果显示:这7株分离株S1基因与我国常用的MASS型疫苗株H120之间核苷酸相似性为77.3%~81.9%,氨基酸序列相似性为75.2%~80.2%;N基因与4/91、H120疫苗株核苷酸相似性均为85.9%~89.1%。上述结果表明,流行株与经典疫苗株之间的序列差异较大。S1与N基因遗传进化分析显示:7株IBV中5株的S1基因属于GI-19(QX-type),2株分别属于GI-22(CK/CH/LSC/99-type)和GI-28(LDT3-type);6株N基因属于LX4-type,1株属于CK/CH/LSC/99-type。这7株IBV主要以QX-type为流行株,其中有3株发生了重组。这说明目前广东省主要流行QX-type毒株,但基因重组发生频率高,本研究为加强广东省鸡传染性支气管炎的免疫防控提供了参考。  相似文献   

11.
12.
One nephropathogenic infectious bronchitis virus (IBV) strain was isolated from Qingdao city, named as QD isolate.S1 gene of the strain was amplified, cloned and sequenced. The S1 gene of QD isolate was composed of 1620 nucleotides, and a spike glycoprotein cleavage recognition site was Arg-Arg-Phe-Arg-Arg. The nucleotide acid similarities among the nine IBV vaccine strains and the QD strain were 78.8% to 82.2%. Phylogenetic analysis based on the S1 genes showed that QD strain and the vaccine strains belonged to different clusters, and showed larger evolutionary distances, but showed the smaller evolutionary distances with the field nephropathogenic IBV strains in China. The result showed that nephropathogenic IBV strains were widely popular in China, and the QD strain could be used as the infectious bronchitis vaccine candidate strain.  相似文献   

13.
Infectious bronchitis virus (IBV) poses a severe threat to the poultry industry and causes heavy economic losses worldwide. Vaccination is the most effective method of preventing infection and controlling the spread of IBV, but currently available inactivated and attenuated virus vaccines have some disadvantages. We developed a chimeric virus-like particle (VLP)-based candidate vaccine for IBV protection. The chimeric VLP was composed of matrix 1 protein from avian influenza H5N1 virus and a fusion protein neuraminidase (NA)/spike 1 (S1) that was generated by fusing IBV S1 protein to the cytoplasmic and transmembrane domains of NA protein of avian influenza H5N1 virus. The chimeric VLPs elicited significantly higher S1-specific antibody responses in intramuscularly immunized mice and chickens than inactivated IBV viruses. Furthermore, the chimeric VLPs induced significantly higher neutralization antibody levels than inactivated H120 virus in SPF chickens. Finally, the chimeric VLPs induced significantly higher IL-4 production in mice. These results demonstrate that chimeric VLPs have the potential for use in vaccines against IBV infection.  相似文献   

14.
Infectious bronchitis (IB) is an economically important viral disease with worldwide distribution. Every country with an intensive poultry industry has infectious bronchitis virus (IBV). The virus rapidly spreads from bird to bird through horizontal transmission by aerosol or ingestion. Sentinel bird studies were carried out in southern Ontario and IBV has been isolated from layer flocks. Genetic analysis of the S1 region of the strains showed that they were not vaccine related. The pathogenicity of selected Ontario variants of IBV isolates was studied and the subsequent work was to determine the degree of protection against field isolates provided by a commonly used vaccine MILDVAC-Ma5 in Ontario. The protection was evaluated by challenging immunized chickens with the respiratory (IBV-ON1) and nephropathogenic (IBV-ON4) viruses. The mean vaccine efficacy for IBV-ON1 was 66.7% indicating that a Massachusetts serotype vaccine would provide some protection against IBV field isolates.  相似文献   

15.
16.
Avian infectious bronchitis virus (IBV) causes tremendous economic losses to the poultry industry worldwide. Different serotypes of this virus show little cross-protection. The present study investigated the genotypic relationship between CK/CH/LDL/97I-type strains and reference IBVs based on S1 gene comparisons and the protection provided by vaccination with commercial vaccines and attenuated homologous and heterologous strains. Phylogenetic analysis and the comparison of S1 showed that CK/CH/LDL/97I-type virus might be a new serotype compared to vaccine strains and other types of IBV isolates in China. Protection efficacy was evaluated by morbidity, mortality, and virus re-isolation from the challenged chicks. Complete protection by IBV vaccination was provided by the homologous strain but sufficient respiratory protection was not provided by the commercial vaccines. Heterologous strains against CK/CH/LDL/97I challenge and the development of a vaccine against CK/CH/LDL/97I-type IBV will be necessary to control infectious bronchitis disease in poultry. Further development of the attenuated CK/CH/LDL/97I strain may provide a valuable contribution towards this goal.  相似文献   

17.
为研究山东省鸡传染性支气管炎病毒(IBV)的遗传变异规律,本研究2006年~2010年从山东省发病的商品鸡中分离鉴定了17株IBV,并对其S1基因、N基因和M基因分别进行RT-PCR扩增、测序及遗传进化分析.序列分析结果表明:与疫苗株H120相比,17个分离株S1蛋白的变异程度较大,存在广泛的基因突变和氨基酸替代,多数病毒株还存在氨基酸的插入;N蛋白无碱基的缺失和插入,仅存在核苷酸的突变和氨基酸的替代;M蛋白除病毒株CK/CH/SD09/005插入3个碱基外,其它16个分离株仅存在少数的碱基突变和氨基酸替代.S1基因、N基因和M基因的系统进化分析结果表明多数分离株的3个基因在进化上相对平行,与国内分离株LX4同属一个进化分支,同源性较高;分离株SDYT0605的3个基因与疫苗株H120同源性较高,可能是免疫压力下变异的疫苗株;分离株SDTA06111、SDWF0608和CK/CH/SD09/005的S1基因、N基因和M基因分属于不同的进化分支,可能发生了基因重组.本研究结果显示基因突变、插入和不同基因之间的重组是免疫压力下IBV变异的主要方式.  相似文献   

18.
Avian metapneumovirus (aMPV), Newcastle disease virus (NDV), and infectious bronchitis virus (IBV) are important respiratory pathogens of chickens. To achieve early posthatch protection against all three diseases it would be helpful to deliver live aMPV, IBV, and NDV vaccines simultaneously at 1 day of age. However, previous work has indicated that the efficacy of aMPV vaccines may be affected when codelivered with IBV or NDV vaccines. The efficacy of an aMPV vaccine when codelivered to chickens in a trivalent combination with an NDV and an IBV vaccine was examined. The serological antibody response to the aMPV vaccine given with the IBV and NDV vaccine was significantly lower than when the aMPV vaccine was given alone. However, the aMPV vaccine did not affect the serological response to the IBV and NDV vaccines. Irrespective, the efficacy of the aMPV vaccine was not affected based on clinical signs postchallenge. This is the first report showing aMPV, IBV, and NDV vaccines can be codelivered without affecting the efficacy of the aMPV vaccine.  相似文献   

19.
The aim of this study was to quantify transmission of infectious bronchitis virus (IBV) H120 vaccine strain among broilers, and to assess whether birds that have been exposed to vaccine strain-shedding birds were protected against clinical signs after infection with a virulent strain of the same serotype. A transmission experiment and a replicate were carried out, each with six groups of commercial broilers. At day of hatch (n = 30) or at 15 days of age (n = 20), half of each group was inoculated with either IBV H120 vaccine (H120 group), virulent IBV M41 (M41 group), or were mock-infected, thereby contact-exposing the other half of each group. Nasal discharge was recorded, and antibody response and virus shedding were measured. To measure clinical protection, four weeks after inoculation all birds, in all groups, were challenged with IBV M41. The reproduction ratio (R; the average number of contact infections caused by one infectious bird) was determined to quantify virus transmission. All contact-exposed birds, except for one in an H120 group, became infected with either IBV H120 or IBV M41. Almost all birds contact-infected with IBV H120 or IBV M41 were subsequently protected against clinical signs after challenge with IBV M41. The lower limits of the 95% confidence interval (CI) of the R of IBV H120 vaccine, and of IBV M41, were significantly <1. For both IBV H120 and IBV M41, the 95% CI was [2.1-infinity] following inoculation at day of hatch and [1.8-infinity] after inoculation at 15 days of age. This finding demonstrates that IBV H120 vaccine is able to spread extensively among broilers. This implies that this vaccine strain might be able to become endemically present in the poultry population. It also implies that, even if not all birds received vaccine during spray application, due to the ability of the vaccine to spread in the flock, they will most likely be protected against clinical signs after a subsequent field virus infection.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号